STAAR Surgical Company (STAA)
NASDAQ: STAA · IEX Real-Time Price · USD
44.69
-1.27 (-2.76%)
At close: May 1, 2024, 4:00 PM
45.00
+0.31 (0.69%)
After-hours: May 1, 2024, 4:37 PM EDT
STAAR Surgical Company Employees
STAAR Surgical Company had 1,115 employees on December 29, 2023. The number of employees increased by 151 or 15.66% compared to the previous year.
Employees
1,115
Change (1Y)
151
Growth (1Y)
15.66%
Revenue / Employee
$289,161
Profits / Employee
$19,145
Market Cap
2.20B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 29, 2023 | 1,115 | 151 | 15.66% |
Dec 30, 2022 | 964 | 158 | 19.60% |
Dec 31, 2021 | 806 | 231 | 40.17% |
Dec 31, 2020 | 575 | 25 | 4.55% |
Dec 31, 2019 | 550 | 75 | 15.79% |
Dec 28, 2018 | 475 | 122 | 34.56% |
Dec 29, 2017 | 353 | 17 | 5.06% |
Dec 31, 2016 | 336 | -24 | -6.67% |
Dec 31, 2015 | 360 | 60 | 20.00% |
Dec 31, 2014 | 300 | -35 | -10.45% |
Dec 31, 2013 | 335 | 34 | 11.30% |
Dec 28, 2012 | 301 | 4 | 1.35% |
Dec 30, 2011 | 297 | 18 | 6.45% |
Dec 31, 2010 | 279 | -17 | -5.74% |
Dec 31, 2009 | 296 | -90 | -23.32% |
Dec 31, 2008 | 386 | -22 | -5.39% |
Dec 28, 2007 | 408 | 124 | 43.66% |
Dec 29, 2006 | 284 | 17 | 6.37% |
Dec 30, 2005 | 267 | 20 | 8.10% |
Dec 31, 2004 | 247 | -11 | -4.26% |
Dec 31, 2003 | 258 | 21 | 8.86% |
Dec 31, 2002 | 237 | -21 | -8.14% |
Dec 28, 2001 | 258 | -76 | -22.75% |
Dec 29, 2000 | 334 | 53 | 18.86% |
Dec 31, 1999 | 281 | 11 | 4.07% |
Dec 31, 1998 | 270 | 1 | 0.37% |
Dec 31, 1997 | 269 | 14 | 5.49% |
Dec 31, 1996 | 255 | 29 | 12.83% |
Dec 29, 1995 | 226 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
ICU Medical | 14,000 |
LifeStance Health Group | 9,325 |
Patterson Companies | 7,600 |
Teladoc Health | 5,600 |
Integra LifeSciences Holdings | 3,946 |
Tandem Diabetes Care | 2,400 |
Corcept Therapeutics | 352 |
Vericel | 314 |
STAA News
- 22 hours ago - STAAR Surgical Strengthens Leadership Team with Appointments of Nancy Sabin as Chief Marketing Officer and Nathaniel Sisitsky as General Counsel - Business Wire
- 2 days ago - STAAR Surgical to Report First Quarter Results on May 7, 2024 - Business Wire
- 26 days ago - What's going on with STAAR Surgical shares? - Invezz
- 27 days ago - STAAR Surgical Announces Preliminary Net Sales for First Quarter 2024 - Business Wire
- 4 weeks ago - STAAR Surgical Celebrates Three Million Lens Milestone at ASCRS Meeting, Unveils New EVO ICL Data and Latest Innovation for 2024 - Business Wire
- 6 weeks ago - STAAR Surgical Celebrates Three Million Implantable Collamer® Lenses - Business Wire
- 7 weeks ago - STAAR Surgical Adds Arthur Butcher and Wei Jiang to Board of Directors - Business Wire
- 2 months ago - STAAR Surgical to Participate in Two Upcoming Investor Conferences - Business Wire